BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine

The biological functions of N6-methyladenosine (m6A) modification of mRNA have recently received a great deal of attention. In previous studies, m6A methylation modification has been shown to regulate mRNA fate and to be crucial for the progression and development of tumors. BTG2 (B-cell translocation gene 2) is a member of BTG/TOB anti-proliferative protein family. BTG2 could inhibit cell proliferation and migration and regulate the cell cycle progression. In this study, we confirm that BTG2 is frequently down-regulated in renal cell carcinoma (RCC) tissues and its low expression is associated with unfavorable prognosis and decreased m6A level. Moreover, we found that m6A methylation modifies the 5’UTR of BTG2 to promote its mRNA stability by binding to IGF2BP2. It has been shown that CRISPR/dCas13b-METLL3 can specifically increase BTG2 m6A modification to significantly increase its m6A and expression levels. Then m6A hypermethylation in BTG2 mRNA could dramatically inhibit RCC cells proliferation and migration, and induce cells apoptosis. Taken together, our data show that BTG2 functions as a tumor suppressor and is frequently silenced via m6A modification in RCC.

[1]  Yaoting Gui,et al.  Targeted Demethylation of the PLOD2 mRNA Inhibits the Proliferation and Migration of Renal Cell Carcinoma , 2021, Frontiers in Molecular Biosciences.

[2]  David R. Liu,et al.  Programmable m6A modification of cellular RNAs with a Cas13-directed methyltransferase , 2020, Nature Biotechnology.

[3]  Arumugam Paramasivam,et al.  N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases , 2019, Hypertension Research.

[4]  Hailing Shi,et al.  Regulation of Co-transcriptional Pre-mRNA Splicing by m6A through the Low-Complexity Protein hnRNPG. , 2019, Molecular cell.

[5]  S. Horner,et al.  Regulation of Viral Infection by the RNA Modification N6-methyladenosine. , 2019, Annual review of virology.

[6]  Mengda Cao,et al.  Detection of N6-methyladenosine modification residues (Review) , 2019, International journal of molecular medicine.

[7]  J. Hanna,et al.  The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy , 2018, Circulation.

[8]  Wei Huang,et al.  Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes , 2018, The Journal of clinical endocrinology and metabolism.

[9]  Yu-Ying He,et al.  The Role of Dynamic m6A RNA Methylation in Photobiology , 2019, Photochemistry and photobiology.

[10]  Z. Ignatova,et al.  Dynamic m6A methylation facilitates mRNA triaging to stress granules , 2018, Life Science Alliance.

[11]  Jernej Ule,et al.  The SMAD2/3 interactome reveals that TGFβ controls m6A mRNA methylation in pluripotency , 2018, Nature.

[12]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[13]  Tao Pan,et al.  Dynamic RNA Modifications in Gene Expression Regulation , 2017, Cell.

[14]  O. Ilkayeva,et al.  N6-methyladenosine is required for the hypoxic stabilization of specific mRNAs , 2017, RNA.

[15]  Chuan He,et al.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.

[16]  He Xiao,et al.  Expression of B-cell translocation gene 2 is associated with favorable prognosis in hepatocellular carcinoma patients and sensitizes irradiation-induced hepatocellular carcinoma cell apoptosis in vitro and in nude mice. , 2017, Oncology letters.

[17]  Jie Jin,et al.  FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. , 2017, Cancer cell.

[18]  Chuan He,et al.  Post-transcriptional gene regulation by mRNA modifications , 2016, Nature Reviews Molecular Cell Biology.

[19]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[20]  R. Gregory,et al.  The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. , 2016, Molecular cell.

[21]  Chuanzhao Zhang,et al.  Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA , 2016, Proceedings of the National Academy of Sciences.

[22]  Shu-Bing Qian,et al.  Dynamic m6A mRNA methylation directs translational control of heat shock response , 2015, Nature.

[23]  Yi Xing,et al.  m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. , 2014, Cell stem cell.

[24]  Jun Li,et al.  Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. , 2014, The Journal of urology.

[25]  Zhike Lu,et al.  m6A-dependent regulation of messenger RNA stability , 2013, Nature.

[26]  Minoru Yoshida,et al.  RNA-Methylation-Dependent RNA Processing Controls the Speed of the Circadian Clock , 2013, Cell.

[27]  O. Elemento,et al.  Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons , 2012, Cell.

[28]  M. Kupiec,et al.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.

[29]  S. Ramaswamy,et al.  Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib , 2011, Oncogene.

[30]  G. S. Winkler,et al.  The mammalian anti‐proliferative BTG/Tob protein family , 2010, Journal of cellular physiology.

[31]  Tsung-Cheng Chang,et al.  Human TOB, an Antiproliferative Transcription Factor, Is a Poly(A)-Binding Protein-Dependent Positive Regulator of Cytoplasmic mRNA Deadenylation , 2007, Molecular and Cellular Biology.

[32]  J. Mclaughlin,et al.  The epidemiology of renal cell carcinoma. , 2006, The Journal of urology.

[33]  I. Lim,et al.  TIS21/BTG2/PC3 as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule , 2006, Journal of Cancer Research and Clinical Oncology.

[34]  Holger Moch,et al.  Impaired Expression of the Cell Cycle Regulator BTG2 Is Common in Clear Cell Renal Cell Carcinoma , 2004, Cancer Research.

[35]  K. Beemon,et al.  Sequence specificity of mRNA N6-adenosine methyltransferase. , 1990, The Journal of biological chemistry.

[36]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.